With a title
like that, not many people will stumble upon this post with Google.
So, for the
hard-core of readers, today I am going to develop an idea of Martha Herbert,
the pediatric neuroscientist from Harvard, who writes a lot about autism.
Incidentally,
most researchers do not like publicity, and particularly those looking at
autism. Martha, herself makes some side
remarks as to why this is; as I suggested in earlier posts it dates back 10+
years to a certain Dr Wakefield.
“A further barrier to considering the body’s impact on the
brain was the reaction to the work of Wakefield, who argued not only that
there was a link between autism
and vaccines but
also that this
link was mediated through the gastrointestinal system. For the better part of a
decade any attempt to discuss gastrointestinal or immune issues with
autism was construed as a support of Wakefield’s vaccine hypothesis, and it
was difficult to discuss, let alone get funding for, clinical or research
observations about these problems. One
way around the essentially taboo character of somatic problems in autism was to treat them as coincidental
symptoms. For example, one could
talk about gut problems provided one made it clear that they did not cause the autism in the brain. Improvement
after treatment of gut problems, which is often observed, would then be
explained as a consequence of reduction of pain and discomfort, but not of
any direct impact on core brain
mechanisms generating autistic behaviors.”
Another fearless autism researcher, not shy to voice his opinions by blog and
tweet, is Paul Whiteley, in Sunderland. Paul
is very much a believer in the role the gut/diet in autism, he and Paul Shattock are
the driving force behind the gluten and casein free diet as a therapy for
autism. Given what Martha writes above,
and the association between Shattock and Wakefield, is it surprising that the GCF
diet remains on the fringes? I know some
parents who wholly endorse it.
Here is a link to one of Martha’s recent works, for Herbert fans:-
Dynamic Encephalopathy
It was Martha who called autism
a dynamic Encephalopathy.
Encephalopathy just means a brain disease.
What she means is that over
time autism changes, day to day and year to year. Just as during fever, autism symptoms may
wane, other environmental provocations may cause flare ups. With age come hormonal changes that will inevitably
change the central hormonal homeostasis, I hope for the better, as generally is
the case.
Other than being a fancy word, Encephalopathy,
is probably a much better word than autism.
There are many types of Encephalopathy and there are multiple causes, it
refers to a syndrome of global brain dysfunction; this syndrome can have
many different organic and inorganic causes.
As with autism the hallmark of encephalopathy is an altered mental state.
If you have not already
opened up Wikipedia, I suggest you do.
From my desk research and
primary research, I know that one factor behind this encephalophy is chronic inflammation,
otherwise known as neuroinflammation.
At this point, we should look at
what neuroscience can tell us about neuroinflammation
The
Dana Foundation is a private philanthropic organization committed to advancing
brain research. Founded in 1950 and with
$230+ million in assets I think they should be a good source. Here
is an excellent paper, that is written for non-scientists.
Among the many interesting
insights are these:-
“Until
recently the CNS and peripheral immune system were thought to operate
independently.”
“However, new research has led to
important advances in our understanding of how immune-related events in the
periphery can influence CNS processes, thereby altering cognition, mood, and
behavior, and these advances are suggesting that inflammation may have
important long term implications for the brain.”
“Inflammation
in the body can lead to inflammation in the brain”
“The same cytokines
that participate in producing the inflammatory response in the body also
initiate the communication process to the CNS. They accumulate in the
bloodstream and thereby travel to the brain”
“They cross into the
brain in regions where the barrier is weak, and they bind to receptors on the
insides of the cerebral vascular blood vessels, thereby inducing the production
of soluble mediators within the epithelial cells that can cross into the brain.”
“In addition, there
are neural as well as blood-borne communication routes. For example, there are cytokine receptors on
nerves, such as the vagus, that innervate peripheral immune organs, and these
nerves communicate to the brain and are activated during infection.”
“During a normal
infection, neuroinflammation and the resulting adaptive sickness behaviors
persist only for several days. However, if these responses become exaggerated
or prolonged, the outcomes may well become established, leading to cognitive
impairment instead of brief memory disruption,”
“… physiology can
become pathology when a set of processes designed to be relatively brief
becomes prolonged.”
“However, peripheral
inflammation is highly complex and involves many immune cells and their
products. Existing anti-inflammatory drugs often target only one of these. For
example, non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen,
inhibit only a hormone, prostaglandins, leaving other actors in inflammation
(cytokines, chemokines, etc.) untouched.”
“A second way that
central neuroinflammation could be prolonged is less obvious. The CNS may come
to over-respond to the same signal from the peripheral immune system. As noted
above, microglia and the cytokines they produce when activated are at the core
of the neuroinflammatory response that produces sickness behaviors. If
microglia were to become “sensitized,” which means they respond in exaggerated
or prolonged fashion, then sickness behaviors would become intensified and
prolonged—pathology instead of physiology.”
“Most encouragingly,
studies in numerous animal models show that the development and expression of
chronic pain can be blocked with drugs that inhibit either microglial
activation within the spinal cord, or the inflammatory cytokines that microglia
produce.”
“In addition,
microglia also can become sensitized without a prolonged peripheral
inflammation. For example, aging appears to sensitize microglia so that
microglia, particularly in the hippocampus, respond in exaggerated fashion to
input. Thus, neuroinflammation produced by surgery, peripheral infection, and
the like, is greatly exaggerated in aged subjects. Correspondingly, aging also
augments the chances of depressive behaviors, cognitive impairments, and pain
produced by peripheral inflammatory events. Encouragingly, however, some human
studies show that inhibition of microglia and cytokines in the brain blunts
such pathological outcomes.”
“Blockade of
inflammation in the periphery and microglial activation/cytokine action in the
CNS, may well become important therapies for a range of disorders not often
thought of as mediated by these factors.”
Conclusion
There is nothing new to me in
the Dana paper; this in itself is rather a shock. If you have followed my blog from the start,
you should also not be surprised; but I
have never seen quite so much scientific good sense written in just four pages. It tells me a lot and reassures me that I am
on the right track with my cytokine blocking therapies, mast cell stabilization and somewhat far fetched, vagus nerve stimmulation ideas.
There are other science-based "inflammation control"
therapies and I will be writing about them later.
P.S. Why no Dean’s List for Martha?
Regular
readers of my blog may have noticed that a small number of the several
hundred researchers, whose papers are discussed here, are given a pat on the
back and moved to the Dean’s List. Why
not Martha?
There is a
good reason. For many years Martha keeps
going on about the “Fever Effect” in autism.
This is the strange phenomenon where autistic behaviours abate during
fever, i.e. sickness associated with high temperature. I myself witness this every time Monty, aged
10 with ASD, has a high temperature. I
think that conclusively solving this, might indeed tell us something profound
about this wide phenotype of autism.
I think with
the resources of Harvard, she should be able to figure this out. Her TRANSCEND Program gives her a pool of
research subjects.
Peter has just one mouse model of autism and,
at the age of 10, he is getting a big to be called a mouse.
So Martha,
put aside the MRIs and the calcium channelopathies, if you figure it out before
me, you get on the Dean’s List.
If I can
prove the underlying reason, I will put myself on the Dean’s List.